Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases

Alvarez, Milena Rodriguez; Valencia, Laura Melissa Rodríguez; Seidman, Roberta; Acharya, Ajita; Espina, Noel; Ravindran, Nadish; Mishan, Daniel; Mesa, Christopher J; Espinoza, Luis R.; McFarlane, Isabel M.

doi:10.1007/s10067-020-05221-1

Cited by 12 publications

(13 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is characterized by inflammatory CSF and radiological evidence of meningeal enhancement with or without underlying parenchymal signal changes. Many of these cases indicate that rheumatoid meningitis can co-exist with high levels of anti-CCP antibodies in both the serum and CSF (12)(13)(14).…”

Section: Discussionmentioning

confidence: 99%

Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis

et al. 2022

View full text Add to dashboard Cite

We herein report a 72-year-old woman with rheumatoid vasculitis who exhibited a depressed level of consciousness after receiving the first dose of the Pfizer-BioNTech mRNA BNT162b COVID-19 vaccine and was diagnosed with meningoencephalitis. Although there was no confirmatory examination, the diagnosis was based on magnetic resonance imaging (MRI) findings and etiological assessments, including microbiological and autoimmune investigations. Both intravenous steroid pulse and gammaglobulin therapies alleviated the patient's symptoms, and the MRI findings improved. Although the efficacy of COVID-19 vaccination has been widely accepted, such neurologic complications might occur in patients with rheumatoid diseases or vasculitis syndromes.

show abstract

Section: Discussionmentioning

confidence: 99%

Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis

et al. 2022

View full text Add to dashboard Cite

show abstract

“…However, in the present study, a total recovery rate of 54.54% and a mortality rate of 14.05% were observed. Most recent reviews have highlighted the good prognosis of the disease [4,9].…”

Section: Discussionmentioning

confidence: 99%

“…RM was first described in 1954 by Ellman et al [3] and has been traditionally associated with long‐standing active disease. However, it may be present at the time of diagnosis [4].…”

Section: Introductionmentioning

confidence: 99%

Rheumatoid meningitis: A systematic review and meta‐analysis

Villa

Sarquis

Grazia

et al. 2021

Euro J of Neurology

View full text Add to dashboard Cite

Rheumatoid arthritis (RA) is a systemic inflammatory disease that commonly presents with inflammation and pain in the joints but may also cause extra-articular manifestations affecting different organs, including the central nervous system (CNS). Neurological manifestations have been classically classified in CNS vasculitis, rheumatoid nodules (RNs) and rheumatoid meningitis (RM) [1,2]. RM was first

show abstract

“…Although some features of our RM case are consistent with the literature, there are also some novel aspects. First, in the literature, only 10 patients who developed RM before RA have been reported [2,3] , rendering our case original and relatively rare. Second, to the best of our knowledge, although ACPA are present in the serum of almost all RM patients, ACPA in the CSF has not previously been reported.…”

Section: Case Presentationmentioning

confidence: 99%

“…Although neurological disorders in RA patients are rare, the peripheral nervous system is mostly involved, with peripheral neuropathy, while central nervous system involvement affects the meninges in particular [1] . RM is rare, but has previously been described in the literature [2,3] . RM patients are generally aged between 60 and 65 years, and more than 50% of them have been followed for RA for less than 10 years.…”

Section: Case Presentationmentioning

confidence: 99%

Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis

Chouk

Halb

Mekhail

et al. 2021

European Journal of Case Reports in Internal Medicine

View full text Add to dashboard Cite

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized mainly by arthritis, with the possible occurrence of extra-articular manifestations. We report the case of a patient who developed leptomeningitis as the first sign of RA, one year before the diagnosis of RA. Methylprednisolone 1000 mg was given intravenously. Because of the onset of seizures and cognitive impairment, rituximab was started. After three cycles of rituximab (1000 mg on day 0 and 1000 mg on day 15, every 6 months), neurological clinical examination, MRI and electroencephalogram findings were significantly improved.

show abstract

Rheumatoid meningitis and infection in absence of rheumatoid arthritis history: review of 31 cases

Cited by 12 publications

References 49 publications

Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis

Acute Meningoencephalitis after COVID-19 Vaccination in an Adult Patient with Rheumatoid Vasculitis

Rheumatoid meningitis: A systematic review and meta‐analysis

Efficacy of Rituximab on Rheumatoid Leptomeningitis as the First Symptom of Rheumatoid Arthritis

Contact Info

Product

Resources

About